This trial is evaluating whether Music & Memory will improve 1 primary outcome and 8 secondary outcomes in patients with Dementia. Measurement will happen over the course of 4 months.
This trial requires 810 total participants across 2 different treatment groups
This trial involves 2 different treatments. Music & Memory is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"The leading theory of AD pathogenesis contends that brain cells that secrete certain proteins in the body that deposit in the space between the white matter and the grey matter of the brain, called interstitial amyloid plaques. These plaques block blood vessels and create the classic amyloid angiopathy that leads to senile vascular changes in the brain." - Anonymous Online Contributor
"Currently, there is no effective treatment for Alzheimer's disease that is able to delay or halt the course of disease. It is possible that research will yield treatments that will delay the course of the disease.\n" - Anonymous Online Contributor
"There are very few cures for AD. Data from a recent study does not suggest any that exist and we believe that it is possible to view the disease as a process of gradual change, with the patient undergoing many transformations." - Anonymous Online Contributor
"Signs may include problems with language production leading to difficulty with speech, and problems with thought such as confusion, loss of memory and visual problems. There may be sensory problems such as numbness, tingling and pain, memory problems such as difficulty remembering which day of the week it is or which family member was ill, and problems with balance, walking and gait.\n" - Anonymous Online Contributor
"The estimated number of people diagnosed with AD annually in the United States in 2012 was 3.0 million. For AD, the proportion of people who die of AD was 10.8% and the proportion of dementia patients who die after losing independence was 4%." - Anonymous Online Contributor
"Alzheimer disease is a chronic brain disease that is characterized by progressive loss of mental abilities (e.g.: memory, thinking, speech etc.), and behavioural disturbances such as forgetfulness and anxiety. AD has very few reliable symptoms or signs. About 1 in 15 people will be diagnosed with AD by the time they are 90 years old." - Anonymous Online Contributor
"A familial pattern, including a greater number siblings of people with Alzheimers disease than of controls, was shown in the group. Considering the frequency of genetic disorders and the increased risk of dementia in these patients in families where siblings have neurodegenerative disease, we find our results consistent with the hypothesis of a genetic contribution to Alzheimer's disease." - Anonymous Online Contributor
"The average age of onset of Alzheimer's disease in Canada is 79.9 years. It begins to appear in earlier life in women than men. It affects the elderly more than young adults. Only a small proportion dies before the age of 65, but most dies between the ages of 65 and 74. These data allow us to predict that in Canada, 0.7% of the population will have an age-specific diagnosis of Alzheimer's disease before age 65, 6.4% will be diagnosed before the age of 75, and 11.8% will have an age-specific diagnosis after the age of 75." - Anonymous Online Contributor
"In the clinic, music & memory may be combined with other treatments such as CBT, cognitive behavioral therapy, therapy (education, support groups) or medications; however, these additional treatments must be evaluated in their effects on memory and mood. More research is needed before recommending the combination approach, particularly when treating patients with mild to moderate dementia." - Anonymous Online Contributor
"Although treatment of neuropharmaceuticals, for example, has shown promise for slowing disease onset, most results so far have failed to provide a cure for AD through the use of currently approved therapies. There has also been extensive research investigating the possibility of developing novel medications for the treatment of AD. A review of the pharmaceuticals in development shows that they are a highly heterogeneous group, and that the number of drugs is relatively small. To find the most promising ones, we recommend reviewing the most recently published clinical research and reviewing the latest studies in progress. At the same time, we need to be realistic about the likelihood that any future drugs developed will be effective in treating AD." - Anonymous Online Contributor
"Side effects are common for every one of these drugs, but not necessarily every day when you take them. For long term treatment, your doctors are responsible for monitoring your progress and managing side effects." - Anonymous Online Contributor
"This article reports on music and memory for therapeutic use, and describes some of the newest developments in this area. New approaches for music have shown a possible role in improving both memory and mental health, and a number of researchers are now investigating this connection. The music therapist is ideally positioned to facilitate and manage these interactions." - Anonymous Online Contributor